In the lifecycle of a pharmaceutical product, initial regulatory approval is often just the beginning. A newly authorized drug typically enters the market with a carefully defined label specifying the disease, population, dose, and setting for its use based on data from randomized controlled trials (RCTs). But often label specifications evolve. Real world clinical needs… Continue reading Label Expansion and the Role of RWD
Tag: Methodology
Methodological Challenges in RWE Research in Pediatrics
In the evolving landscape of evidence generation, Real-World Data (RWD) has emerged as a vital source of insights across the product lifecycle. However, when it comes to pediatric populations, the generation of Real-World Evidence (RWE) has its unique challenges, both scientific and structural. Children are not just “small adults”; they represent a highly heterogeneous group… Continue reading Methodological Challenges in RWE Research in Pediatrics
Methodological Considerations in RWD Studies by Intended Use
The growing acceptance of real-world data (RWD) and real-world evidence (RWE) has expanded the horizon for how we generate insights to support decision-making across the product lifecycle. However, while the value of RWD is increasingly recognized by regulators, payers, and safety bodies, the design and methodological rigor of these studies must be carefully tailored to… Continue reading Methodological Considerations in RWD Studies by Intended Use
Bridging Gaps in Oncology RWE: Key Challenges and Practical Solutions
The growing use of real-world data (RWD) in oncology is essential to complement the limitations of clinical trials, which often involve narrowly selected patient populations under specific conditions. In contrast, RWD captures how cancer care is delivered in routine practice across diverse demographics, comorbidities, and healthcare systems. This is particularly critical in oncology, where treatment… Continue reading Bridging Gaps in Oncology RWE: Key Challenges and Practical Solutions
Digital Biomarkers: Transforming Healthcare Through Continuous and Real-World Monitoring
Digital biomarkers are revolutionizing the way healthcare professionals and researchers monitor, diagnose, and treat diseases. Enabled by digital technologies, these biomarkers provide objective, quantifiable physiological and behavioral data collected through connected devices such as smartphones, wearables, and sensors. Unlike traditional biomarkers, which rely on laboratory tests or imaging, digital biomarkers enable continuous, real-world monitoring, offering… Continue reading Digital Biomarkers: Transforming Healthcare Through Continuous and Real-World Monitoring